AI-Driven Drug Discovery
AMD Invests $20 Million in Absci to Revolutionize AI-Driven Drug Discovery
AMD has made public a strategic investment of $20 million for Absci Corporation, one of the leading generative AI drug discovery companies. In collaboration...